Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Acquisition

26 Sep 2006 07:03

Cello Group plc26 September 2006 26 September 2006 CELLO ACQUIRES STRATEGY & RESEARCH CONSULTANCY SMT Cello Group plc ("Cello", AIM: CLL), the research and data led marketingservices group, has acquired SMT Consulting Limited ("SMT"), a leading strategyand research consultancy specialising in the fast growing market of business andcompetitive intelligence. Initial consideration consists of up to £6.2 millionwith further performance related consideration of up to £8.8 million. SMT's client base includes around 20% of the FTSE 100 companies and a number ofFortune 500 corporations in the areas of financial services, nuclear &utilities, telecoms and FMCG. It is based in Oxford, employs approximately 35people and also has an office in Shenzhen, China. The initial consideration consists of up to £6.2 million of which £4.2 millionis payable in cash and the balance satisfied by the issue of 1,542,480 newordinary shares. In addition, there are further performance related paymentsover the period to 31 December 2010. These payments are in a mixture of loannotes and new ordinary shares at Cello's discretion, with a maximum shareelement of 75%. In order to finance the cash element of the acquisition, Cello has entered intoa new £12 million committed three year banking facility. Following thetransaction, Cello has net debt of approximately £2 million. For the year to 30 April 2006, SMT had a turnover of £3.4 million and normalisedprofits before tax of £0.8 million. Net assets at 30 April 2006 were £0.7million including cash of £0.5 million. Application has been made to the London Stock Exchange for the new shares to beadmitted to AIM and it is expected that admission will take place by 29September 2006. Kevin Steeds, Cello Group's Chairman, said: "SMT is an exciting addition to the Cello Group, further strengthening ourupstream research and consulting offer. With its impressive client franchise inthe UK and Asia, SMT also helps accelerate the development of our internationaloffering." Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8461 College HillAdrian Duffield/Ben Way 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello Group plc is a research and data led marketing services group that listedon AIM in November 2004. The Group's strategy is to create value for shareholders by building a portfolioof companies around three specialist platforms, each operating within adifferent niche of the marketing services sector: market research and planning,brand strategy and consultancy, and direct marketing, digital and databasemanagement. Each of Cello's three platforms has significant organic and acquisitive growthpotential; blue chip client relationships with a history of client loyalty;experienced, high quality management teams; and a track record of profitability. Cello Planning and Research * Insight Research Group - London, New York and Basel Insight is a specialist healthcare market research business that offers a broadrange of quantitative and qualitative research based solutions. Its clientsinclude GlaxoSmithKline, Novartis, AstraZeneca, Shire Pharmaceuticals,NovoNordisk, Boehringer Ingleheim, Lundbeck, Pfizer, Roche and Merck, Sharp andDohme. Insight recently acquired FML, a leading field force company. * Leapfrog Research and Planning - Windsor and New York Leapfrog is a leading consumer market research and planning consultancy offeringqualitative and quantitative research in the UK and internationally. It actsfor a number of blue chip clients including Tesco, GSK, BBC, Scottish Courage,Toyota, AA, RHM and Wyeth. * RS Consulting - London RS Consulting is a quantitative market research and business consultancy. Basedin London, the company employs approx 80 people across its three subsidiaries.Major clients include hp, Xerox, Sony, FedEx, Department of Work & Pensions,Cisco Systems, AXA, Yell, RBS, AON and BUPA. Cello Brand Consulting * Leith - Edinburgh and London Leith is the largest and most successful branding agency in Scotland. Theagency has been voted Scottish Agency of the Year for the last five years.Leith opened a London office in 2000 which has recently been integrated withFarm. Leith's major clients include Irn Bru, Scottish Executive, Standard LifeBank, Standard Life, Smile, ICI, FT and Goodfellas Pizza. * The Value Engineers - Beaconsfield TVE is a leading strategic brand consultancy focused on four core disciplines;branding, strategy, insight and innovation. Clients include Unilever,Carlsberg, Diageo, Sony Ericsson, ICI, Visa, BP, T-Mobile and Britvic. * TMI - Redditch Formed in 1978 TMI UK employs some 60 staff and is a leading provider oforganisational development and consultancy solutions to a range of blue chipclients including Toyota, hp, Metronet, Marks and Spencer, the Foreign andCommonwealth Office, National Express Group and Serco Solutions. Cello Response * Target Group - Cheltenham and Cirencester Target is the leading direct and database marketing consultancy specialising inthe "not-for-profit" and charity sector. The agency works for five of the top20 charities in the UK. Target is expanding into the "grey sector" of productsand services for older people for clients such as National Trust, Saga andWhich? Limited. Target has a leading database subsidiary, Talking Numbers and asuccessful print management operation, Target Direct Print. * Navigator Responsive Advertising - Edinburgh Navigator Responsive Advertising, Scotland's leading direct marketing agency,provides responsive communication solutions for a wide range of clientsincluding HBOS Group, De Vere Resort Ownership, ScottishPower, Abbey and RemyMartin. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Jan 20157:00 amRNSPRE-CLOSE TRADING STATEMENT
16th Jan 20155:15 pmRNSBlocklisting Interim Review
6th Jan 20154:50 pmRNSTotal Voting Rights
9th Dec 20147:00 amRNSAcquisition of Worldwide Promedica Inc
28th Nov 20141:10 pmRNSTotal Voting Rights
3rd Nov 201410:58 amRNSTotal Voting Rights
2nd Oct 201410:59 amRNSDirector/PDMR Shareholding
1st Oct 20141:05 pmRNSTotal Voting Rights
19th Sep 20144:10 pmRNSDirector/PDMR Shareholding
17th Sep 20147:00 amRNSInterim Results
1st Sep 20147:00 amRNSHolding(s) in Company
29th Aug 20147:00 amRNSTotal Voting Rights
31st Jul 20147:00 amRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Update
1st Jul 20143:54 pmRNSBlocklisting Interim Review
1st Jul 201412:24 pmRNSTotal Voting Rights
25th Jun 20141:27 pmRNSIssue of Equity
18th Jun 20147:00 amRNSDirector/PDMR Shareholding
3rd Jun 20142:02 pmRNSDirector/PDMR Shareholding
30th May 20147:00 amRNSTotal Voting Rights
13th May 20141:00 pmRNSResults of Annual General Meeting
13th May 20147:00 amRNSAGM STATEMENT
13th May 20147:00 amRNSAcquisition of iS Healthcare Dynamics
8th May 20147:00 amRNSAdditional listing/TVR
30th Apr 20143:25 pmRNSTotal Voting Rights
25th Apr 20147:00 amRNSAcquisition of Line Digital
14th Apr 201412:17 pmRNSAnnual Report & Accounts 2013 & Notice of AGM
31st Mar 20147:00 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results for the Year Ended 31 Dec 2013
28th Feb 20147:00 amRNSTotal Voting Rights
3rd Feb 20147:00 amRNSTotal Voting Rights
22nd Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
7th Jan 20142:17 pmRNSBlocklisting Interim Review
17th Oct 201310:53 amRNSDirector/PDMR Shareholding
11th Oct 201311:36 amRNSTransaction in Own Shares
11th Oct 20137:00 amRNSDirector/PDMR Shareholding
1st Oct 20132:58 pmRNSTotal Voting Rights
27th Sep 201311:42 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSDirector/PDMR Shareholding
18th Sep 20137:00 amRNSInterim Results
13th Sep 201312:07 pmRNSIssue of Equity
17th Jul 20137:00 amRNSTrading update
8th Jul 201312:26 pmRNSTransaction in Own Shares
4th Jul 201310:00 amRNSDirector/PDMR Shareholding
14th Jun 20137:00 amRNSBlock Listing Application
3rd Jun 20133:12 pmRNSDirector/PDMR Shareholding
31st May 20139:00 amRNSTotal Voting Rights
21st May 201312:53 pmRNSDirector/PDMR Shareholding
15th May 201312:12 pmRNSHolding(s) in Company
14th May 20132:49 pmRNSResults of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.